The effect of cognitive behavior therapy-based psychotherapy applied in a forest environment on physiological changes and remission of major depressive disorder

Psychiatry Investigation

Volumn 6, Issue 4, 2009, Pages 245-254

  Kim, Won ^a   Lim, Seoung Kyeon ^a   Chung, Eun Joo ^a   Woo, Jong Min ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

Cognitive behavior therapy; Forest; Major depressive disorder; Remission

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE THERAPY; CONTROLLED STUDY; FEMALE; FOREST; HAMILTON SCALE; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTPATIENT; REMISSION;

EID: 75649134959     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2009.6.4.245     Document Type: Article

References (48)

1. Wells KB, Stewart A, Hays RD, Bumam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989;262:914-919.
2. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic survey. JAMA 1990;264:2524-2528.
3. Mathers C, Lopez A, Stein C, Fat DM, Rao C, Inoue M, et al. Deaths and disease burden by cause. CDPP working paper 18. Bethesda (MD): National Institute of Health; 2004.
4. Faravelli C, Ambonetti A, Palanti S, Pazzagli A. Depressive relapses and incomplete recovery from index episode. Am J Psychiatry 1986; 143:888-891.
5. Depression Guideline Panel: Depression in Primary Care, volume 2: Treatment of Major Depression: Clinical Practice Guideline 5: AHCPR Publication 93-0051. Rockville, Md, US Department of Health Care Policy and Research; 1993.
6. Boerner RJ, Müller HJ. The importance of new antidepressants in the treatment of anxiety/depressive disorders. Pharmacopsychiatry 1999; 32:119-126.
7. Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, et al. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gen Psychiatry 1998;55:694-700.
8. Paykel ES, Ramana R, Cooper Z, Hayhurst H, Kerr J, Barocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995:25:1171-1180.
9. Ward KS. New developments in antidepressant therapy. Nurs Clin North Am 2005;40:95-105.
10. Keller MB. Remission versus response: the new gold standard of antidepressant care. J Clin Psychiatry 2004;65 Suppl 4:53-59.
11. Anderson IM, Nutt DJ, Deakin JF. Evidence-based Guidelines for treating depressive disorders with antidepressants: a revision ofthe 1993 British Association for Psychopharmacology guidelines. British Association for Psychopharmacology. J Psychopharmacol 2000;143-20.
12. Korean Society of Depressive and Bipolar disorder (KSDB) Committee of practice guideline for depressive disorder. Practice guideline for depressive disorder. Korean Association of Medical Science. Ministry of Health, Welfare, and Family affair; 2008.
13. Thase ME, Entsuah AR, Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors. Br J Psychiatry 2001;178:234-241.
14. Casacalenda N, Perry JC, Looper K. Remission in major depressive disorder: a comparison of pharmacotherapy, psychotherapy, and control conditions. Am J Psychiatry 2002;159:1354-1360.
15. Raybum NR, Otto MW. Cognitive-behavioral therapy for panic disorder: a review of treatment elements, strategies, and outcomes. CNS Spectr 2003;8356-362.
16. Cuijpers P, van Straten A, Warmerdam L. Behavioral activation treatments of depression: a meta-analysis. Clin Psychol Rev 2007;27:318-326.
17. Beck AT. Cognitive therapy of depression. NY: The Guilford Press; 1979.
18. Kim W. Cognitive-behavioral therapy for depressive disorders: reality and advance. J of Kor Soc for Dep and Bip Disorders 2008;6:67-72.
19. Teasdale JD, Segal ZV, Williams JM, Ridgeway VA, Soulsby JM, Lau MA. Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol 2000;68:615-623.
20. Duckworth AL, Steen TA, Seligman MEP. Positive psychology in clinical pratice. Annual Rev of Clinical Psychology 2005;1:629-625.
21. Seligman ME, Steen TA, Park N, Peterson C. Positive psychology progress; empirical validation of interventions. Am Psychol 2005;60: 410-421.
22. Townsend M. Feel blue? Touch green! Participation in forest/woodland management as a treatment for depression. Urban For Urban Green 2006:5:111-120.
23. Nilson K. Forest, trees and human health and wellbeing. Urban For Urban Green 2006;5:109.
24. Tsunetsugu Y, Park BJ, Ishii H, Hiran H, Kagawa T, Miyazaki Y. Physiological effects of Shinrin-yoku (taking in the atmosphere of the forest) in an old-growth broad leaf forest in Yamagata Prefecture, Japan. J Physiol Anthropol 2007:26:135-142.
25. Kaplan S. The restorative effects of nature: toward an integrative framework. J Environ Psychol 1995;16:169-182.
26. Chang CY, Hammitt WE, Chen PK, Machnik L, Su WC. Psychophysiological responses and restorative value of natural environments in Taiwan. Landsc Urban Plan 2008:85:79-84.
27. Lynn L. What is the therapeutic value of camping for emotionally disturbed girls? Women Ther 1994;15:129-137.
28. Pryor A, Carpenter C, Townsend M. Outdoor education and bush adventure therapy: a socio-ecological approach to health and wellbeing. Aust J Outdoor Edu 2005;93-13.
29. Berman DD, Anton MT. A wilderness therapy program and an alternative to adolescent psychiatric hospitalization. Residential Treat Child Youth 1988;5:41-53.
30. Hughes AH, Dudley HK Jr. An old idea for an new problem: camping as a treatment for the emotionally disturbed in our state hospitals. Adolescence 1973;8:43-50.
31. Polenz D, Rubitz F. Staff perceptions of the effect of therapeutic camping upon psychiatric patients' affect. Ther Recreation J 1977;11: 70-73.
32. Hahn OS, Ahn JH, Song SH, Cho MJ, Kim JK, Bae JN, et al. Development of Korean Version of Structured Clinical Interview Schedule for DSM-IV Axis I disorder: interrater reliability. J Korean Neuropsychiatr Assoc 2000;39:362-372.
33. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
34. Yi JS, Bae SO, Ahn YM, Park DB, Noh KS, Shin HK, et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scales (K-HDRS). J Korean Neuropsychiatr Assoc 2005:44:456-465.
35. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
36. Ahn YM, Lee KY, Yi JS, Kang MH, Kim DH, Kim JL, et ai. A Validation Study of the Korean-vesion Montgomery-Asberg Depression Rating Scale. J Korean Neuropsychiatr Assoc 2005;44:466-476.
37. Beck AT. Depression: clinical, experimental and theoretical aspects. New York: Harper & Row; 1967.
38. Song JY. A study ofthe reliability and validity of BDI, SDS, and MMPI-D scales. J of Korean Psychology Assoc Clinical 1991;10:98-113.
39. Ware JE Jr, Sherboume CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-483.
40. Koh SB, Chang SJ, Kang MG, Cha BS, Park JK. Reliability and validity on measurement instrument for Health Status Assessment in Occupational Workers. Korean J Prev Med 1997;30:251-266.
41. Keller SD, Ware JE Jr, Bentler PM, Aaronson NK, Alonso J, Apolone G, et al. Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol 1998;51:1179-1188.
42. Wolf MM, Varigos GA, Hunt D, Sloman JG. Sinus arrhythmia in acute myocardial infarction. Med J Aust 1978;2:52-53.
43. Kim W, Woo JM, Chae JH. Heart rate variability in psychiatry. J Korean Neuropsychiatr Assoc 2005;44:176-184.
44. Gathrighta J, Yamada Y, Moritab M. Comparison of the physiological and psychological benefits of tree and tower climbing. Urban For Urban Green 2006:5:141-149.
45. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000;23:477-501.
46. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression: a prospective study. J Psychiatr Res 2001;35:83-94.
47. Burbach FR. The efficacy of physical activity interventions within mental health services: Anxiety and depressive disorders. J Mental Health 1997;6:543-566.
48. Jacobson NS, Dobson KS, Truax PA, Addis ME, Koerner K, Gollan JK, et al. A component analysis of cognitive-behavioral treatment for depression. J Consult Clin Psychol 1996;64:295-304.